Developments in Postmarketing Safety Surveillance of Medical Products: Reflections from the FDA Sentinel Innovation Center
VirtualJoin us on Wednesday, January 28th for a Department of Epidemiology seminar featuring Dr. Rishi Desai discussing Developments in Postmarketing Safety Surveillance of Medical Products: Reflections from the FDA Sentinel Innovation Center. Abstract: The U.S. Food and Drug Administration (FDA) Sentinel Initiative—launched in 2008 under the FDA Amendments Act as the first national active-surveillance system for medical-product safety—has grown from a proof-of-concept...